Kidney drug showed no clear short-term effect on minerals in urine
In a crossover trial, 15 adults with autosomal dominant polycystic kidney disease took empagliflozin or placebo for 14 days each.In a crossover trial, 15 adults with autosomal dominant polycystic kidney disease took empagliflozin or placebo for 14 days each.